
Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …

Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …
Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …

